
Sanofi has released its Q2 2026 aide-mémoire document on its investor website to assist financial modeling for the upcoming quarterly results. This memo includes details on non-comparable items, currency impacts, and share count. The full Q2 2026 earnings report will be published on July 30, 2026. Sanofi continues to focus on innovation in biopharma and AI to drive long-term growth and improve global health outcomes.